Skip to content

Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery

Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery: A Pilot Study for Assessment of Recovery Parameters

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01985854
Enrollment
60
Registered
2013-11-15
Start date
2014-01-31
Completion date
Unknown
Last updated
2013-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Elective Craniotomy

Keywords

Desflurane, Propofol, Total intravenous anesthesia, Neurosurgery

Brief summary

Since neurological testing during neurosurgery, such as somato-sensory evoked potentials, motor-evoked potentials, auditory evoked potentials and visual evoked potentials are well maintained their wave-form reactivity with total intravenous anaesthesia technique better than inhalational anesthetic techniques, the standard anesthesia method for neurosurgery is usually total intravenous anaesthesia technique. Nonetheless, after finishing recording the evoked potential responses during surgery, facilitation of recovery from general anesthesia is getting important, because the real neurological physical examination is much more sensitive than above electrical evoked potentials to evaluate the results of surgical operation. We propose to evaluate the recovery parameters after conversion from total intravenous anaesthesia technique to Desflurane anesthesia during long term neurosurgery procedures. The conversion will be initiated upon completion of the neurophysiological electric evoked potentials assessment. Based on the pharmacological properties of desflurane, we hypothesize that recovery after conversion to Desflurane will be faster compared to recovery after total intravenous anaesthesia alone.

Interventions

DRUGPropofol
DRUGDesflurane

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
Tokyo Women's Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing elective craniotomy * American Society of Anesthesiology Physical Status Ⅰ, II and III * Age: between 20 to 65 years * Sex: male or female * Patients who are postmenopausal or surgically sterilized * Expected Operation time is longer than 4 hours.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Time from the discontinuation of anesthesia to extubationPatients will be followed in the operation room, an expected average of 30 minutes.

Secondary

MeasureTime frameDescription
Time from the discontinuation of anesthesia to eye openingAt the end of surgery, duration time from the discontinuation of anesthesia to the eye opening will be measured, averaged expected time is 30 minutes
Cognitive functionUp to 24 hoursCognitive function will be measured by Mini-Mental state examination at baseline (preoperatively) 5 minutes and 24 hours after extubation. Postoperative recovery function will be also measured by Post-operative Quality Recovery Scale (PQRS scale) at 5 minutes and 24 hours after extubation.
Time from the discontinuation of anesthesia to orientationUp to 24 hoursTime from the discontinuation of anesthesia to orientation (State name, state the date of birth)

Other

MeasureTime frame
Length of ICU stayPatients will be followed for the duration of intensive care unit stay, an expected average of 1 week

Countries

Japan

Contacts

Primary ContactMakoto Ozaki, Ph.D
mozaki@anes.twmu.ac.jp81-3-3353-8111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026